ClinicalTrials.govpublic full text
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease
hepatitis c virus infection, sickle cell disease, gilead, hepatitis c, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 900963
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.